# BAYERCROP (BAYERCROP) — Stock analysis > Faxioms all-in-one stock review. Canonical page: https://faxioms.com/stocks/bayercrop ## Current market snapshot - Exchange: NSE - Country: India - Price: ₹3,770.6 - Change: -3.15% - As of: 2026-09-18 - 1D return: -3.14% - 5D return: -5.21% - 1M return: -7.27% - Latest complete quarter: — ## Faxioms Analysis _As of 2026-09-18_ ### Technical Outlook As of September 18, 2026, BAYERCROP is trading at ₹3771.0, and the daily technical picture indicates a bearish trend. This is supported by the price being below key daily moving averages (EMA 20, EMA 50, SMA 20, SMA 50, SMA 200) and the Supertrend indicator pointing downwards. The weekly timeframe also shows a bearish trend with the price below its weekly moving averages and Supertrend. However, the monthly timeframe presents a conflicting signal, with the Supertrend indicator suggesting a bullish trend, although the price is below its monthly EMA 20 and SMA 20. Nearest resistance is observed at ₹3801.6, approximately 0.81% above the current price. Support levels are not explicitly provided in the data. Recent market activity includes a "volume_with_price_move" anomaly on September 18, 2026, characterized by extreme downward movement and a high volume ratio of 5.7, alongside a downward gap on September 11, 2026. The stock's current drawdown is -0.42, with annualized volatility at 26%. Key conditions to watch include the price's ability to overcome the nearest resistance at ₹3801.6. A sustained move above this level could signal a shift in the short-term technical stance. Conversely, a break below recent lows, especially on increased volume, would reinforce the prevailing bearish trend across daily and weekly timeframes. - Current price as of September 18, 2026: ₹3771.0. - Daily and weekly timeframes show a bearish trend, with the price below key moving averages and Supertrend. - Monthly timeframe shows a conflicting bullish Supertrend signal, despite price being below short-term monthly averages. - Nearest resistance level identified at ₹3801.6 (0.81% above current price). - Watch for price action around ₹3801.6 for potential shifts in the technical outlook. - Inside Bar - Bearish Engulfing Reversal - Harami - Outside Bar - Evening Star ### News Context Bayer CropScience's financial performance shows a mixed trend. While the company reported a significant increase in cash flow from operating activities, rising from ₹433 crore in March 2019 to ₹666 crore in March 2020, and a corresponding jump in free cash flow from ₹378 crore to ₹638 crore over the same period, its compounded sales growth for the trailing twelve months (TTM) was negative at -3%. However, compounded profit growth for the TTM was a strong 24%, and 5-year compounded profit growth stood at 7%. The balance sheet indicates an increase in equity capital from ₹34 crore to ₹45 crore and a rise in reserves from ₹2,205 crore to ₹2,528 crore between March 2019 and March 2020. Investments also saw a substantial increase, from ₹0 crore to ₹41 crore in the same period, while borrowings remained minimal at ₹2 crore in March 2020. Technical indicators suggest a bearish trend on a daily and weekly basis, with the Supertrend indicator at 4038.26 and 4418.4 respectively, and the ADX at 37.78 on the daily chart indicating strong trend momentum. However, the monthly trend shows a bullish Supertrend at 2782.12 with a lower ADX of 15.09. - Bayer CropScience's cash flow from operations increased to ₹666 crore in March 2020 from ₹433 crore in March 2019. - Free cash flow rose to ₹638 crore in March 2020, up from ₹378 crore in March 2019. - The company reported a TTM compounded profit growth of 24% and a 5-year compounded profit growth of 7%. - TTM compounded sales growth was -3% as of the latest reporting period. - Daily and weekly technical trends are indicated as bearish, while the monthly trend is bullish. ### What Changed Bayer CropScience (BAYERCROP) on the NSE experienced a price decrease between its previous observation and the current report date of September 18, 2026. The price moved from ₹3893.4 to ₹3771.0. No new filings or news were reported for the company during this period. The company's profile and exchange listing remain unchanged. - On 2026-09-18, Bayer CropScience's stock price was ₹3771.0. - The stock price on the previous observation date was ₹3893.4. - No new filings or news were reported as of 2026-09-18. ### Official Filings Bayer CropScience Limited's financial position shows a notable increase in total assets from ₹3,549 crore in March 2019 to ₹3,836 crore in March 2020. This growth is accompanied by a rise in equity capital from ₹34 crore to ₹45 crore and reserves from ₹2,205 crore to ₹2,528 crore over the same period. The company's cash flow from operating activities significantly increased to ₹666 crore in March 2020 from ₹433 crore in March 2019, contributing to a higher free cash flow of ₹638 crore compared to ₹378 crore in the prior year. While borrowings remained minimal at ₹2 crore in March 2020, investments increased to ₹41 crore from ₹0. The company's compounded profit growth over 5 years was 7%, with a TTM (Trailing Twelve Months) growth of 24%, contrasting with a TTM sales growth of -3% over the same 5-year period which saw compounded sales growth of 6%. Technically, as of September 18, 2026, the daily trend indicates a bearish sentiment with the Supertrend indicator at ₹4,038.26. Moving averages such as the 20-day EMA (₹3,977.64) and 50-day SMA (₹4,106.84) are also above the current closing price of ₹3,771.0. The weekly trend also shows a bearish Supertrend at ₹4,418.4. However, the monthly trend shows a bullish Supertrend at ₹2,782.12, suggesting a potential divergence in longer-term outlooks. The stock has experienced significant negative returns across various periods, with a 1-year return of -27% and a year-to-date return of -17%. The current drawdown is -42%. - Total assets increased to ₹3,836 crore in March 2020 from ₹3,549 crore in March 2019. - Equity capital rose to ₹45 crore and reserves to ₹2,528 crore by March 2020. - Cash flow from operating activities improved to ₹666 crore in March 2020, up from ₹433 crore in March 2019. - Free cash flow increased to ₹638 crore in March 2020, from ₹378 crore in March 2019. - Compounded profit growth was 7% over 5 years and 24% TTM, while compounded sales growth was 6% over 5 years and -3% TTM. - Daily and weekly technical trends are bearish as of September 18, 2026. - The stock has experienced a 1-year return of -27% and a current drawdown of -42%. ### Fundamentals Bayer CropScience's recent operating performance shows a mixed trajectory. For the fiscal year ending March 2024, the company reported sales of ₹5,106 crore, a slight decrease from ₹5,140 crore in the prior year. Operating profit for the same period was ₹959 crore, up from ₹924 crore year-on-year, indicating an improvement in operating margins to 19.0% from 18.0%. Net profit, however, saw a decline to ₹740 crore in FY24 from ₹758 crore in FY23. Looking ahead, projections for the fiscal year ending March 2025 indicate an increase in sales to ₹5,473 crore and operating profit to ₹691 crore, though this represents a decrease in operating profit margin to 13.0%. Net profit is estimated to fall to ₹568 crore. For the fiscal year ending March 2026, sales are projected to reach ₹5,675 crore, with operating profit expected to rise to ₹874 crore and net profit to ₹689 crore, with an operating margin of 15.0% and a net profit margin of approximately 12.1%. Financially, the company's borrowings have decreased from ₹74 crore in March 2023 to ₹47 crore in March 2024. Equity capital has remained stable at ₹45 crore from March 2022 to March 2026. Free cash flow was ₹912 crore in FY24, a significant increase from ₹537 crore in FY23, but is projected to decrease to ₹222 crore in FY25 before rising to ₹1,014 crore in FY26. The company's return on equity has been strong, reported at 24% for the last year. - For the year ending March 2024, sales were ₹5,106 crore, a decrease from ₹5,140 crore in the prior year. - Operating profit for the year ending March 2024 was ₹959 crore, an increase from ₹924 crore year-on-year, with operating margins at 19.0%. - Net profit for the year ending March 2024 was ₹740 crore, a decrease from ₹758 crore in the prior year. - Projected sales for the year ending March 2025 are ₹5,473 crore, with an estimated net profit of ₹568 crore. - Projected sales for the year ending March 2026 are ₹5,675 crore, with an estimated net profit of ₹689 crore. - Borrowings decreased to ₹47 crore as of March 2024 from ₹74 crore in March 2023. - Free Cash Flow was ₹912 crore for the year ending March 2024, projected to decrease to ₹222 crore for the year ending March 2025. ### Bull Case Bayer CropScience has demonstrated a significant increase in its cash flow from operations, rising from ₹433.0 in March 2019 to ₹666.0 in March 2020. This growth in operating cash flow has contributed to a substantial rise in free cash flow, which increased from ₹378.0 to ₹638.0 over the same period. The company also saw its equity capital grow from ₹34.0 in March 2019 to ₹45.0 in March 2020, alongside an increase in reserves from ₹2205.0 to ₹2528.0. Investments also saw a notable increase, from ₹0 in March 2019 to ₹41.0 in March 2020. - Cash flow from operating activities increased to ₹666.0 in March 2020 from ₹433.0 in March 2019. - Free cash flow grew to ₹638.0 in March 2020, up from ₹378.0 in March 2019. - Equity capital increased to ₹45.0 in March 2020 from ₹34.0 in March 2019. - Reserves grew to ₹2528.0 in March 2020, compared to ₹2205.0 in March 2019. ### Bear Case The company's financial performance shows a recent sales decline, with Compounded Sales Growth at -3% for the Trailing Twelve Months (TTM), contrasting with a positive 6% over five years. While profit growth has been stronger at 24% TTM and 7% over five years, the recent sales trend warrants attention. Operationally, cash flow from operations has decreased to ₹666.0 in March 2020 from ₹433.0 in March 2019, though the metric 'CFO/OP' saw a decline from 132.0 to 110.0 over the same periods. The company's balance sheet shows an increase in borrowings to ₹2 crore in March 2020 from ₹0 in March 2019, alongside a rise in Capital Work In Progress (CWIP) to ₹56 crore from ₹47 crore and investments from ₹0 to ₹41 crore. Technical indicators suggest a bearish trend on a daily timeframe, with the Supertrend indicator at 4038.26 and the 14-day ADX at 37.78, indicating strong bearish momentum. Weekly trends also show a bearish Supertrend direction at 4418.4. - Compounded Sales Growth was -3% for the Trailing Twelve Months (TTM) as of March 2020, down from 6% over 5 years. - Borrowings increased to ₹2 crore in March 2020 from ₹0 in March 2019. - Capital Work In Progress (CWIP) rose to ₹56 crore in March 2020 from ₹47 crore in March 2019. - The daily technical trend shows a bearish Supertrend direction with the indicator at 4038.26 as of September 18, 2026. - The weekly technical trend also indicates a bearish Supertrend direction at 4418.4. ### FAQs **How has Bayer CropScience's financial position changed between March 2019 and March 2020?** Between March 2019 and March 2020, Bayer CropScience saw an increase in its Total Assets from ₹3,549 crore to ₹3,836 crore. This growth was accompanied by an increase in Equity Capital from ₹34 crore to ₹45 crore and Reserves from ₹2,205 crore to ₹2,528 crore. Total Liabilities also increased from ₹3,549 crore to ₹3,836 crore. Notably, Borrowings increased from ₹0 crore to ₹2 crore, while Investments rose significantly from ₹0 crore to ₹41 crore. Fixed Assets grew from ₹440 crore to ₹468 crore, and CWIP (Construction Work in Progress) increased from ₹47 crore to ₹56 crore. Other Assets also saw an increase from ₹3,062 crore to ₹3,270 crore, while Other Liabilities decreased slightly from ₹1,310 crore to ₹1,262 crore. **What has been the trend in Bayer CropScience's cash flow from operations and investing activities?** In the fiscal year ending March 2020, Bayer CropScience's Cash from Operating Activity was ₹666 crore, an increase from ₹433 crore in March 2019. However, Cash from Investing Activity was a net outflow of ₹29 crore in March 2020, compared to a larger outflow of ₹113 crore in March 2019. Free Cash Flow improved to ₹638 crore in March 2020 from ₹378 crore in March 2019. The company's Net Cash Flow also increased to ₹489 crore in March 2020 from ₹162 crore in March 2019. Cash from Financing Activity remained a net outflow, decreasing slightly from ₹158 crore in March 2019 to ₹148 crore in March 2020. **What are the recent performance trends for Bayer CropScience's sales and profits?** Over the last five years, Bayer CropScience has achieved a Compounded Profit Growth of 7% and a Compounded Sales Growth of 6%. On a Trailing Twelve Months (TTM) basis, the company shows a Compounded Profit Growth of 24%, but a Compounded Sales Growth of -3%. **What is the current technical trend and key price levels for Bayer CropScience?** As of September 18, 2026, the daily trend for Bayer CropScience indicates a bearish Supertrend direction at ₹4,038.26, with the closing price at ₹3,771.0. Technical indicators like ADX (37.78) suggest strong trending conditions, while the negative slopes of the EMAs and SMAs further support a bearish short-term outlook. The weekly trend also shows a bearish Supertrend direction at ₹4,418.4. However, the monthly trend shows a bullish Supertrend direction at ₹2,782.12. Key resistance levels to monitor are ₹3,801.6, ₹3,845.8, ₹3,869.6, and ₹3,913.8. ## Technical analytics - As of: 2026-09-18 - Daily trend: Strong Downtrend - Weekly trend: Weak Downtrend - Pivot point: ₹3,913.8 - Risk regime: Higher Price Risk ### Resistance levels - 4105 - 4466.9 - 5060.9154296875 ### Return and range metrics | Metric | Value | | --- | --- | | return_1 | -3.14% | | return_10 | -4.79% | | return_1m | -8.15% | | return_1y | -27.45% | | return_20 | -7.27% | | return_3m | -11.66% | | return_5 | -5.21% | | return_6m | -15.93% | | return_since_start | -31.78% | | return_ytd | -17.00% | ### Risk and volatility metrics | Metric | Value | | --- | --- | | state | high_risk | | label | Higher price risk | | summary | Recent drawdown or price variability is materially high and may lead to larger short-term outcomes. | | maximum_drawdown | -41.83% | | annualized_volatility | +26.02% | ## Quarterly financials Quarterly financials are not currently available. ## Official filings No official filings are currently available. ## News and market events - 2026-08-07 — CNBC-TV18: **Sensex Today | Stock Market Live Updates: GIFT Nifty 90 pts lower; Jefferies raises target for Premier Eng** — Sensex Today | Stock Market Live Updates: The index holding on to 24,500 levels on the downside is something that the bulls will be pleased with as analysts believe it is forming a base for a move, first towards 24,800, and eventually to record levels. Crude oil prices though, have staged a minor rebound overnight with brent returning to above $80 a barrel. — [Source](https://www.cnbctv18.com/market/stock-market-live-updates-sensex-nifty-50-today-cas-tata-hero-pgel-lic-sci-sbi-ncc-premier-crompton-midcaps-share-price-liveblog-19963799.htm) - 2026-08-05 — CNBC-TV18: **Stocks to Watch for August 6: Cummins India, Biocon, PB Fintech, Aurobindo Pharma and more** — Stocks such as Navin Fluorine International, Cummins India, PB Fintech, JK Lakshmi Cement, Neuland Laboratories and Aster DM Quality Care will be in focus on Thursday after reporting their June-quarter earnings post market hours on Wednesday. Investors will also track companies scheduled to announce their June-quarter results during the day for stock-specific cues. — [Source](https://www.cnbctv18.com/photos/market/stocks-to-watch-for-august-6-cummins-india-biocon-pb-fintech-and-more-19962532.htm) - 2026-08-05 — CNBC-TV18: **Stocks to Watch for August 6: Cummins India, Biocon, PB Fintech and more** — Stocks such as Navin Fluorine International, Cummins India, PB Fintech, JK Lakshmi Cement, Neuland Laboratories and Aster DM Quality Care will be in focus on Thursday after reporting their June-quarter earnings post market hours on Wednesday. Investors will also track companies scheduled to announce their June-quarter results during the day for stock-specific cues. — [Source](https://www.cnbctv18.com/market/stocks-to-watch-for-august-6-cummins-india-biocon-pb-fintech-and-more-19962532.htm) - 2026-07-28 — CNBC-TV18: **DCM Shriram Q1 net profit jumps over six-fold on higher revenue and EBITDA growth** — Shares of DCM Shriram Ltd ended at ₹1,046.90, up by ₹14.85, or 1.44%, on the BSE. — [Source](https://www.cnbctv18.com/market/stocks/dcm-shriram-share-price-q1-net-profit-jumps-over-six-fold-on-higher-revenue-and-ebitda-growth-19955894.htm) ## Business profile **Strategic vision:** Develops and distributes agricultural solutions for crop protection and seeds. ### Business segments - **Crop Protection:** Provides herbicides, fungicides, insecticides, and seed treatments to protect crops from various threats. - **Seeds:** Develops and distributes high-quality seeds for crops like corn, soybeans, and cotton, incorporating biotechnology traits. - **Environmental Science:** Offers solutions for professional pest management, vector control, and forestry applications. - **Digital Farming:** Provides data-driven tools and platforms to assist farmers in optimizing their decision-making processes. ### Competitive strengths - Extensive investment in research and development for agricultural innovation. - Global operational presence across key agricultural regions. - Focus on sustainable practices and solutions. ## Related stocks - [ANURAS (Chemicals)](https://faxioms.com/stocks/anuras) — +2.46% - [ATUL (Chemicals)](https://faxioms.com/stocks/atul) — +0.50% - [CLEAN (Chemicals)](https://faxioms.com/stocks/clean) — +3.10% - [DEEPAKNTR (Chemicals)](https://faxioms.com/stocks/deepakntr) — -1.26% - [FLUOROCHEM (Chemicals)](https://faxioms.com/stocks/fluorochem) — +2.62% ## Freshness and sources - Data as of: 2026-09-18 - Source: Faxioms public stock analysis API Canonical: https://faxioms.com/stocks/bayercrop Markdown representation: https://faxioms.com/stocks/bayercrop?render=md